Food & nutrition
Non-GMO labels: voluntary claims, bioengineered disclosure and safety assessment
On this page
Non-GMO food wording usually communicates a claim about genetic-engineering methods or ingredient sourcing. FDA’s voluntary-labelling guidance encourages accurate descriptions of that technology and truthful, non-misleading claims. It is not the same statement as a nutrient claim, a clinical benefit claim or the US mandatory bioengineered disclosure.[1]
Similar-looking label statements answer different questions
| Statement or setting | Meaning | Limit |
|---|---|---|
| US voluntary non-engineering statement | Manufacturer claim about method or sourcing | Must be truthful and non-misleading[1] |
| US bioengineered disclosure | Defined detectable modified genetic material | Refining and statutory exclusions matter[2] |
| EU mandatory GM labelling | Genetically modified or produced-from wording | 0.9% exception is ingredient-specific and conditional[4] |
| EU voluntary GM-free label | Additional exclusion measures | Not interchangeable with mandatory-disclosure rules[4] |
A production claim should specify what was excluded
FDA’s guidance prefers technology-specific language such as not genetically engineered. Genetic modification in its broad technical sense includes changes achieved through conventional breeding, making an unqualified “not modified” interpretation misleadingly broad. FDA describes circumstances in which it does not intend to object to truthful GMO wording. Read whether the statement concerns the whole product, a named ingredient or a sourcing practice. A voluntary claim can provide information that a mandatory disclosure does not, but its wording still requires substantiation.[1]
Detectability and origin are different properties
USDA explains that highly refined foods or ingredients without detectable modified genetic material are not bioengineered foods under the disclosure definition. It also distinguishes animal products from the feed an animal ate: that feed alone does not make the resulting food bioengineered. These are boundaries of this particular disclosure system. They should not be converted into a claim that refining makes an ingredient nutritionally better or that every nondisclosed product meets a private non-GMO standard.[2]
Evidence & uncertainty
US bioengineered disclosure depends partly on detectable modified genetic material. Highly refined ingredients with no detectable material can fall outside that definition even when their source crop was bioengineered. Consequently, the absence of a required disclosure cannot be read as proof that no ingredient ever came from such a crop.[2]
Selected-source overview · Independent review pendingPublished questions
Does no bioengineered disclosure prove a food has no engineered-crop ingredients?
Selected-source overview · Independent review pending. Read the evidence context.
No. USDA’s definition excludes highly refined ingredients without detectable modified genetic material. Absence of disclosure therefore does not establish every ingredient’s crop origin.[2]
Evidence behind this answer
- Bioengineered Disclosure Frequently Asked Questions: General
technical or regulatory guidance · Date not stated
Selected original page or document passages inspected; no independent full-document appraisal · Definition, highly refined ingredients and animal feed distinctions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is the EU 0.9 percent GM-labelling exception unconditional?
Selected-source overview · Independent review pending. Read the evidence context.
No. It applies to ingredients considered individually and to adventitious or technically unavoidable presence. Deliberate inclusion is not described as an unconditional exception.[4]
Evidence behind this answer
- Traceability and labelling of genetically modified foods
technical or regulatory guidance · Date not stated
Selected original page or document passages inspected; no independent full-document appraisal · GM Labelling and GM-free labelling; conditional 0.9% exception
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a non-GMO food label demonstrate a nutritional health advantage?
Selected-source overview · Independent review pending. Read the evidence context.
The voluntary claim concerns production or sourcing and must be truthful. That claim alone does not provide a comparison of nutrient amounts or clinical health outcomes.[1]
Evidence behind this answer
- Voluntary Labeling of Foods Derived or Not Derived from Genetically Engineered Plants
technical or regulatory guidance · 2019
Selected original page or document passages inspected; no independent full-document appraisal · Sections III.A–B: truthful claims, preferred terminology and GMO enforcement discretion
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can nondetectability be supported by validated refinement records?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. The US disclosure regulation identifies validated refinement records, non-bioengineered sourcing records and appropriate testing records as possible routes, under its conditions.[3]
Evidence behind this answer
- 7 CFR Part 66: National Bioengineered Food Disclosure Standard
technical or regulatory guidance · Date not stated
Selected original page or document passages inspected; no independent full-document appraisal · Section 66.9: nondetectability records, validated refining and test performance
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do FDA GMO foods have different basic food-safety standards?
Selected-source overview · Independent review pending. Read the evidence context.
FDA says GMO foods must meet the same safety standards as other foods. Its biotechnology consultation considers the safety information for particular new plant varieties.[5]
Evidence behind this answer
- How GMOs Are Regulated in the United States
technical or regulatory guidance · 2024
Selected original page or document passages inspected; no independent full-document appraisal · Same safety standards; agencies; product-specific plant biotechnology consultation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is EU GM labelling the same process as safety authorisation?
Selected-source overview · Independent review pending. Read the evidence context.
No. The European framework has separate aims for safety assessment and authorisation, traceability and labelling. Consumer choice information does not replace product risk assessment.[6]
Evidence behind this answer
- GMO legislation
technical or regulatory guidance · Date not stated
Selected original page or document passages inspected; no independent full-document appraisal · Framework aims: risk assessment, authorisation, traceability and clear labels
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
The disclosure framework relies on product records
The US regulation permits several ways to establish nondetectability, including records of non-bioengineered sourcing, a validated refinement process or appropriate testing records. Validation concerns the method and food; it is not simply a consumer looking for a symbol. Testing quality and maintained records matter. The regulation’s approach recognises that an ingredient’s production history and what an analytical test can detect are different facts. A laboratory result also does not establish the ingredient’s nutrient content, environmental performance or long-term health effects.[3]
The EU exception is not a general non-GMO threshold
European Commission guidance says ingredient lists on packaged GM foods must use the relevant genetically modified or produced-from wording. Its exception applies to no more than 0.9% of an ingredient considered individually, with adventitious or technically unavoidable presence. Those conditions are part of the rule. The Commission separately describes voluntary GM-free measures, which must not mislead. Do not take 0.9% as an unconditional allowance for deliberate inclusion or as a worldwide certification standard.[4]
Safety review is separate from the disclosure category
FDA says GMO foods must meet the same food-safety standards as other foods. Its plant biotechnology consultation considers products individually, using developer-submitted safety information. This is regulatory oversight, not a clinical experiment comparing every non-GMO-labelled product. The claim cannot resolve nutritional differences between foods with different formulations.[5]
Choice information and risk assessment answer different questions
The European framework identifies safety assessment, authorisation, traceability and labelling as separate aims. A shopper may value production-method information for reasons beyond nutrition, but a preference does not demonstrate a biological health advantage. Conversely, a safety assessment does not answer every ethical or environmental concern about a crop or farming system. This page compares the meanings of label systems; it does not independently reappraise every authorised crop. Product-specific composition and assessments are needed for claims that go beyond what a disclosure states.[6]
References
- Voluntary Labeling of Foods Derived or Not Derived from Genetically Engineered Plants
Technical or regulatory guidance
FDA · Content/publication date: 2019
Accessed: 2026-10-13 UTC · Selected original page or document passages inspected; no independent full-document appraisal
Cited sections: Sections III.A–B: truthful claims, preferred terminology and GMO enforcement discretion - Bioengineered Disclosure Frequently Asked Questions: General
Technical or regulatory guidance
USDA AMS · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected original page or document passages inspected; no independent full-document appraisal
Cited sections: Definition, highly refined ingredients and animal feed distinctions - 7 CFR Part 66: National Bioengineered Food Disclosure Standard
Technical or regulatory guidance
eCFR / US Government · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected original page or document passages inspected; no independent full-document appraisal
Cited sections: Section 66.9: nondetectability records, validated refining and test performance - Traceability and labelling of genetically modified foods
Technical or regulatory guidance
European Commission · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected original page or document passages inspected; no independent full-document appraisal
Cited sections: GM Labelling and GM-free labelling; conditional 0.9% exception - How GMOs Are Regulated in the United States
Technical or regulatory guidance
FDA · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Selected original page or document passages inspected; no independent full-document appraisal
Cited sections: Same safety standards; agencies; product-specific plant biotechnology consultation - GMO legislation
Technical or regulatory guidance
European Commission · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected original page or document passages inspected; no independent full-document appraisal
Cited sections: Framework aims: risk assessment, authorisation, traceability and clear labels
Scope & review
- Population
- Consumers comparing packaged food labels; food-specific and jurisdiction-specific conditions are identified
- Exposure or intervention
- Meaning and interpretation of food-label claims, distinct from individual dietary treatment
- Comparison
- Voluntary non-engineering claims versus mandatory US bioengineered disclosure and EU GM statements
- Outcomes
- Label accuracy, nutrient composition, consumer interpretation and source-specific health evidence
- Timeframe
- Current rules and dated guidance checked 13 October 2026; research timeframes are stated separately
- Jurisdiction
- Selected US FDA/USDA disclosure framework and EU Commission guidance; private certification rules are not inferred
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
What this article still leaves open
- What sourcing or testing criteria does a particular private label use?
- Which product-specific assessment supports a claimed nutritional or environmental difference?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.